Skip to main content

Additional Articles by the Authors

Kathryn Fitch, RN, MEd
J. Michael Woolley, PhD
Tyler Engel, ASA, MAAA
Helen Blumen, MD, MBA
Business, Original Research
Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population
Kathryn Fitch, RN, MEd; Xiaoyun Pan, MS, PhD; Jocelyn Lau, MPH; Tyler Engel, ASA, MAAA; Krithika Rajagopalan, MS, PhD
Read More
Business
Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure
Stakeholder Perspective
Validating the Impact of Heart Failure Through the Law of Large Numbers
Read More
Original Research
Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service
Stakeholder Perspective
An Ounce of Prevention Is Not a Choice a Patient Gets to Make for Late-Stage Cancer
Read More
Clinical
Longitudinal Commercial Claims–Based Cost Analysis of Diabetic Retinopathy Screening Patterns
Stakeholder Perspective
The Economics of Screening Patients with Diabetes for Diabetic Retinopathy
Read More
Business
The Economic Burden of Ischemic Stroke and Major Hemorrhage in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation: A Retrospective Claims Analysis
Stakeholder Perspective
The Clinical Toll of Nonvalvular Atrial Fibrillation Poses Significant Economic Burden
Read More
Business
Resource Utilization and Cost in a Commercially Insured Population with Schizophrenia
Stakeholder Perspective
Schizophrenia: “The Forgotten Illness”?
Read More
Clinical
National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs
Read More
Clinical
Estimates of Commercial Population at High Risk for Cardiovascular Events: Impact of Aggressive Cholesterol Reduction
Stakeholder Perspective
The 10,000-Life Measure Shows Real-World Costs of Disease Burden and Interventions on a Population
Read More

Results 1 - 8 of 8